Fidus Invt (FDUS) Share Value Declined While Sumitomo Mitsui Asset Management Company LTD Lowered Its Holding by $1.07 Million; Celgene (CELG) Holder Essex Investment Management Co Lowered Its Holding by $9.52 Million as Shares Declined

May 20, 2018 - By Migdalia James

Celgene Corporation (NASDAQ:CELG) Logo

Sumitomo Mitsui Asset Management Company Ltd decreased its stake in Fidus Invt Corp (FDUS) by 24.87% based on its latest 2017Q4 regulatory filing with the SEC. Sumitomo Mitsui Asset Management Company Ltd sold 71,156 shares as the company’s stock declined 15.97% with the market. The institutional investor held 214,902 shares of the company at the end of 2017Q4, valued at $3.26 million, down from 286,058 at the end of the previous reported quarter. Sumitomo Mitsui Asset Management Company Ltd who had been investing in Fidus Invt Corp for a number of months, seems to be less bullish one the $338.08 million market cap company. The stock decreased 0.36% or $0.05 during the last trading session, reaching $13.82. About 54,406 shares traded. Fidus Investment Corporation (NASDAQ:FDUS) has declined 23.54% since May 20, 2017 and is downtrending. It has underperformed by 35.09% the S&P500.

Essex Investment Management Co Llc decreased its stake in Celgene Corp (CELG) by 78.84% based on its latest 2017Q4 regulatory filing with the SEC. Essex Investment Management Co Llc sold 91,561 shares as the company’s stock declined 19.30% with the market. The hedge fund held 24,573 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $2.56M, down from 116,134 at the end of the previous reported quarter. Essex Investment Management Co Llc who had been investing in Celgene Corp for a number of months, seems to be less bullish one the $56.92B market cap company. The stock decreased 2.01% or $1.61 during the last trading session, reaching $78.37. About 6.79M shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 20, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on July, 26. They expect $1.87 earnings per share, up 11.31% or $0.19 from last year’s $1.68 per share. CELG’s profit will be $1.36 billion for 10.48 P/E if the $1.87 EPS becomes a reality. After $1.61 actual earnings per share reported by Celgene Corporation for the previous quarter, Wall Street now forecasts 16.15% EPS growth.

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Seekingalpha.com which released: “Celgene: Bold Pursuits In Science With 24.66% Discount” on April 23, 2018, also Fool.com with their article: “Celgene Starts the Year With a Bang” published on May 14, 2018, Benzinga.com published: “Celgene CEO: Strong Q1 Led To Improved Full-Year Guidance” on May 04, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Seekingalpha.com and their article: “My 2 Cents On The Ozanimod Saga” published on May 15, 2018 as well as Nasdaq.com‘s news article titled: “These Stocks Have Quadrupled in Just 1 Year” with publication date: May 19, 2018.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.34, from 1.17 in 2017Q3. It turned negative, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Cypress Asset Management Tx stated it has 0.29% in Celgene Corporation (NASDAQ:CELG). First Dallas Secs Inc stated it has 2,663 shares or 0.18% of all its holdings. Patten Gru owns 8,450 shares or 0.35% of their US portfolio. Healthcor Ltd Partnership owns 1.73 million shares. Crestpoint Cap Mgmt Limited Liability Corp has 0.3% invested in Celgene Corporation (NASDAQ:CELG) for 5,100 shares. Calamos Ltd Liability Corp owns 660,250 shares or 0.35% of their US portfolio. Palisade Ltd Nj stated it has 0.03% in Celgene Corporation (NASDAQ:CELG). Meeder Asset Mngmt Inc reported 16,934 shares stake. British Columbia Invest Mngmt Corp has 568,397 shares. Magnetar Fincl Llc owns 6,597 shares for 0.02% of their portfolio. Netherlands-based Bedrijfstakpensioenfonds Voor De Media Pno has invested 1.98% in Celgene Corporation (NASDAQ:CELG). City Holding, a West Virginia-based fund reported 1,938 shares. Sunbelt Secs has invested 0.38% in Celgene Corporation (NASDAQ:CELG). 18,314 are owned by Calamos Wealth Limited Liability Com. Moreover, Aqr Capital Mngmt Lc has 0.48% invested in Celgene Corporation (NASDAQ:CELG) for 4.38 million shares.

Essex Investment Management Co Llc, which manages about $740.27 million and $758.32M US Long portfolio, upped its stake in Codexis Inc (NASDAQ:CDXS) by 75,895 shares to 362,980 shares, valued at $3.03M in 2017Q4, according to the filing. It also increased its holding in Corcept Therapeutics Inc (NASDAQ:CORT) by 144,611 shares in the quarter, for a total of 448,712 shares, and has risen its stake in Diamondback Energy Inc (NASDAQ:FANG).

Since February 8, 2018, it had 1 buy, and 3 sales for $3.58 million activity. $851,093 worth of stock was sold by LOUGHLIN JAMES J on Monday, March 12. Alles Mark J had bought 3,260 shares worth $299,594. $1.77M worth of Celgene Corporation (NASDAQ:CELG) shares were sold by KAPLAN GILLA.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 146 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Friday, June 16 by Leerink Swann. Credit Suisse maintained the shares of CELG in report on Monday, January 8 with “Buy” rating. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, July 6. The stock of Celgene Corporation (NASDAQ:CELG) earned “Hold” rating by JMP Securities on Friday, October 27. The rating was maintained by RBC Capital Markets with “Buy” on Thursday, October 19. The stock has “Buy” rating by Cantor Fitzgerald on Monday, August 28. As per Monday, May 7, the company rating was maintained by Morgan Stanley. Credit Suisse maintained it with “Buy” rating and $128.0 target in Monday, October 30 report. Stifel Nicolaus maintained Celgene Corporation (NASDAQ:CELG) rating on Thursday, July 6. Stifel Nicolaus has “Buy” rating and $13900 target. The firm has “Buy” rating given on Monday, February 5 by Mizuho.

Sumitomo Mitsui Asset Management Company Ltd, which manages about $6.67B US Long portfolio, upped its stake in Ally Finl Inc (NYSE:ALLY) by 91,242 shares to 121,451 shares, valued at $3.54M in 2017Q4, according to the filing. It also increased its holding in Equity Residential (NYSE:EQR) by 34,298 shares in the quarter, for a total of 83,510 shares, and has risen its stake in Ptc Inc (NASDAQ:PTC).

Since March 7, 2018, it had 1 insider purchase, and 0 sales for $91,700 activity.

More important recent Fidus Investment Corporation (NASDAQ:FDUS) news were published by: Nasdaq.com which released: “Fidus Investment Corporation Schedules First Quarter 2018 Earnings Release and Conference Call” on April 25, 2018, also Seekingalpha.com published article titled: “Fidus Investment’s (FDUS) CEO Ed Ross on Q1 2018 Results – Earnings Call Transcript”, Globenewswire.com published: “Fidus Investment Corporation Announces First Quarter 2018 Financial Results” on May 03, 2018. More interesting news about Fidus Investment Corporation (NASDAQ:FDUS) was released by: Seekingalpha.com and their article: “Fidus Investment 2018 Q1 – Results – Earnings Call Slides” with publication date: May 04, 2018.

Among 6 analysts covering Fidus Investment (NASDAQ:FDUS), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. Fidus Investment had 11 analyst reports since January 15, 2016 according to SRatingsIntel. The stock of Fidus Investment Corporation (NASDAQ:FDUS) earned “Hold” rating by Keefe Bruyette & Woods on Sunday, July 23. The firm earned “Neutral” rating on Monday, January 9 by Robert W. Baird. The stock has “Buy” rating by DA Davidson on Friday, September 23. The rating was maintained by Keefe Bruyette & Woods on Wednesday, May 31 with “Hold”. The rating was maintained by Keefe Bruyette & Woods on Sunday, October 22 with “Hold”. Ladenburg initiated the stock with “Buy” rating in Friday, February 16 report. Robert W. Baird maintained the shares of FDUS in report on Friday, November 3 with “Hold” rating. As per Sunday, April 22, the company rating was maintained by Keefe Bruyette & Woods. The rating was maintained by Oppenheimer on Friday, August 4 with “Buy”. The stock has “Mkt Perform” rating by Keefe Bruyette & Woods on Tuesday, January 10.

Celgene Corporation (NASDAQ:CELG) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>